Abstract: The invention relates to a human GHRH-binding protein (human Growth Hormone-releasing hormone). Said protein, which is obtained from the Pilocarpus Heterophyllus plant, can be used to prepare medicaments intended to antagonise the effects of GHRH and to treat proliferative diseases (particularly cancer), acromegaly or diabetic nephropathies and retinopathies.
Type:
Grant
Filed:
February 26, 2002
Date of Patent:
June 10, 2008
Assignee:
Societe de Counseils de Recherches et d'Applications Scientifiques (S.C.R.A.S.)
Inventors:
Eric Ferrandis, Beng Poon Teng, Christine Sohier, Christophe Thurieau